Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 44 CC9 | DOI: 10.1530/endoabs.44.CC9

SFEBES2016 Featured Clinical Cases Featured Clinical Cases (10 abstracts)

Successful treatment of primary aldosteronism with partial adrenalectomy, facilitated by the use of 11C-Metomidate PET/CT

Waiel Bashari 1 , Andrew Powlson 1 , Olympia Koulouri 1 , Denis Quill 2 , Morris Brown 1 , Heok Cheow 1 , Michael Conall Dennedy 2 & Mark Gurnell 1


1Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; 2National University of Ireland & Galway University Hospital, Galway, Ireland.


Background: Primary aldosteronism (PA) is responsible for 5-10% of all cases of HTN. The current gold standard test for determining the side of aldosterone hypersecretion is adrenal vein sampling (AVS). 11C-Metomidate PET/CT (METO-PET) has recently emerged as a potential non-invasive alternative to AVS. As 11C-Metomidate is concentrated within ‘hyperfunctioning’ nodules, METO-PET potentially not only identifies the side, but the exact site of aldosterone hypersecretion, thus allowing more targeted surgical intervention.

Case report: A 45-year-old man was found to have HTN and hypokalaemia after sustaining a myocardial infarction. He required four anti-hypertensive agents to achieve BP control. His aldosterone was elevated with a suppressed renin, and aldosterone did not adequately decrease following saline suppression, confirming the diagnosis of PA. Adrenal CT and MRI did not convincingly show a lesion. He underwent AVS, but the result was inconclusive (right adrenal vein not cannulated). METO-PET revealed increased tracer uptake in a subcentimeter nodule on the left adrenal (Figure 1).

Treatment: He underwent a posterior retroperitoneoscopic procedure, during which the lateral limb of the left adrenal was removed, leaving the rest of the gland in situ. Histology confirmed the presence of a small Conn’s adenoma. The patient is normotensive post-surgery, on no antihypertensive medications, with normal biochemistry.

Conclusion: This case highlights the ability of METO-PET to not only lateralize, but actually localize the site of aldosterone hypersecretion. This allows selective removal of a Conn’s adenoma with sparing of the adjacent normal adrenal gland.

/media/8299/562930g1.gif

Volume 44

Society for Endocrinology BES 2016

Brighton, UK
07 Nov 2016 - 09 Nov 2016

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.